Compounding Pharmacy · Troy, MI · 503A

MediVera Compounding Pharmacy Review

Troy, MI 503A compounding pharmacy, PCAB-accredited in both sterile and non-sterile compounding — a dual accreditation held by fewer than 1% of US compounders. Compounds semaglutide and tirzepatide with third-party potency, sterility, and endotoxin testing, and ships to roughly 49 states.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503APCAB
Location: Troy, MI
States licensed: 1
8.0
★★★★☆4/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from MediVera Compounding Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.4

Luvo Health

Compounded and brand GLP-1s, oral tablets and peptides on one price list

Starting price: $249/mo

Get started →Read review Luvo Health →
8.0

Strut Health

Oral-lozenge compounded GLP-1 access

Starting price: $99/mo

Get started →Read review Strut Health →
7.7

TrimRx

Best overall value

Starting price: $149/mo

Get started →Read review TrimRx →
7.6

Sprout Health

LegitScript-certified compounded GLP-1 via named pharmacies

Starting price: $149/mo

Get started →Read review Sprout Health →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (1)

MI

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for MediVera Compounding Pharmacy. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-07-11 via editorial · How we verify provider data

Frequently Asked Questions

MediVera Compounding Pharmacy is a 503A compounding pharmacy based in Troy, MI. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
MediVera Compounding Pharmacy is headquartered in Troy, MI. The pharmacy is licensed to ship to 1 US states.
MediVera Compounding Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.